Factory 99% Ledipasvir Powder CAS 1256388-51-8 Chemical Intermediate Anti-HCV Ledipasvir

• Customization: Available
• Powder: Yes
• Customized: Customized
• Model NO.: A604
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Elderly, Children, Adult
• State: Powder
• Purity: >99%
• Name: Ledipasvir
• CAS: 1256388-51-8
• Appearance: White Powder
• Assay: 99%
• OEM: Available
• Sample: Available
• Suitable: Adult
• MOQ: 10g
• Function: Anti-HCV
• Transport Package: Foil Bag
• Specification: 99
• Trademark: /
• Origin: China
• Production Capacity: 10000 Kgs Per Month

Product Description

 

Product Name	Ledipasvir
Appearance	White Powder
CAS NO.	1256388-51-8
MF	C27H35N7O3S
Storage	Keep in a cool, dry, dark location

 

Ledipasvir is an antiviral medication used primarily in the treatment of hepatitis C. It belongs to a class of drugs known as NS5A inhibitors, which work by blocking a specific protein (NS5A) involved in the replication of the hepatitis C virus.

 

1. Combination Therapy: Ledipasvir is often used in combination with other antiviral medications, such as sofosbuvir, to treat hepatitis C. This combination therapy has been shown to be highly effective in clearing the virus from the body.
2. Genotype-Specific Treatment: Ledipasvir is particularly effective against certain genotypes of hepatitis C, including genotype 1, which is the most common in the United States and Europe.
3. Oral Administration: Ledipasvir is an oral medication, making it a convenient treatment option for patients with hepatitis C.

1. Inhibition of NS5A Protein: By inhibiting the NS5A protein, ledipasvir prevents the hepatitis C virus from replicating and spreading within the body.
2. Viral Clearance: When used in combination with other antiviral medications, ledipasvir can help to clear the hepatitis C virus from the body, leading to improved liver function and a reduced risk of liver disease progression.
3. Reduced Side Effects: Ledipasvir has been shown to have a relatively low incidence of side effects, making it a well-tolerated treatment option for patients with hepatitis C.